Fischer Medical Ventures is currently trading at Rs. 619.90, up by 18.65 points or 3.10% from its previous closing of Rs. 601.25 on the BSE.
The scrip opened at Rs. 601.30 and has touched a high and low of Rs. 622.85 and Rs. 580.00 respectively. So far 15515 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 792.65 on 14-Jun-2024 and a 52 week low of Rs. 66.80 on 28-Sept-2023.
Last one week high and low of the scrip stood at Rs. 634.80 and Rs. 580.00 respectively. The current market cap of the company is Rs. 3316.47 crore.
The Institutions and Non-Institutions held 6.75% and 93.24%, stake in the company respectively.
Fischer Medical Ventures has signed a Memorandum of Understanding (MoU) with Tech Avant-Garde (TAG), an innovative educational solutions provider, to implement comprehensive health programs in educational institutions across India. This strategic partnership aims to drive holistic healthcare of students and their connected communities to enable healthier and more conducive learning environment.
Fischer MV-TAG collaboration in India will start with screening students through Fischer MV’s Flynn Health Kiosk, a health screening machine that conducts a comprehensive diagnostic of over 60 clinical vital signs parameters within minutes. Eye health, audiology, oral health, mental health, lung & respiratory health checks which are important aspects for students will also be implemented in phases. In parallel, adolescent girls and women’s health will be added to provide a holistic view of each student’s health status every quarterly. Fischer MV-TAG program will also extend beyond students to rope in their parents, teachers, and school communities to achieve the combined mission to foster a healthy connected learning community.
Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: